Results 71 to 80 of about 348 (143)

Zebra Body Not Caused by Fabry Disease. [PDF]

Intern Med, 2023
Fukunaga S, Egawa M, Ito T, Tanabe K.
europepmc   +1 more source

Efficiency of combined systemic glucocorticoids and narrowband ultraviolet B phototherapy in lymphocytic-variant hypereosinophilic syndrome. [PDF]

JAAD Case Rep
Hida Y, Hara T.
europepmc   +1 more source

Usefulness of bepotastine besilate for perennial allergic rhinitis

OTOLOGIA FUKUOKA, 2006
TAKAHASHI, Hirotaka, HONDA, Nobumitsu, HYODO, Masamitsu   +2 more
openaire   +1 more source

Risk Factors for Infusion Reactions Associated With Rituximab Therapy. [PDF]

Cancer Diagn Progn
Amemiya T, Suzuki H.
europepmc   +1 more source

Current perspectives on topical antiallergics. [PDF]

Indian J Ophthalmol
Gokhale NS.
europepmc   +1 more source

Phosphonium Ions as Activating Groups for the Selective Alkylation of Pyridines and Polyazines. [PDF]

J Am Chem Soc
Brunner DA, Thomas DC, Steenback KR, Rozema SD, McNally A.   +4 more
europepmc   +1 more source

Dose-dependent, non-pigmenting fixed drug eruption with eczematous lesions induced by bosutinib: case report. [PDF]

Pan Afr Med J, 2023
Youh J, Yamaguchi Y, Kawamura T, Hoshina D.   +3 more
europepmc   +1 more source

Emerging agents that target signaling pathways in cancer fibroblast cells (Review). [PDF]

Int J Oncol
Wan Y, Liu XQ, Liu D, Li KD, Zhang DD.
europepmc   +1 more source

Dapsone-induced Heinz-body haemolytic anaemia. [PDF]

BMJ Case Rep, 2023
Toyoshima T, Harada Y, Morikawa T, Shimizu T.   +3 more
europepmc   +1 more source

Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study. [PDF]

J Pharm Health Care Sci
Ohtsubo T, Yamamoto K, Matumoto S, Ito K, Sasa Y, Tomishima K, Dote S, Makihara K, Wakasugi Y, Mitsuie T, Yamagiwa K, Sato K, Hasegawa H, Uoshima N, Kitahiro Y, Tomogane K.   +15 more
europepmc   +1 more source